Trial Profile
A Multicenter, Randomized, Double-Masked, Placebo-Controlled, Pilot Study to Evaluate Effects of Emixustat Hydrochloride on Aqueous Humor Biomarkers Associated With Proliferative Diabetic Retinopathy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Emixustat (Primary)
- Indications Diabetic retinopathy
- Focus Biomarker; Pharmacodynamics
- Sponsors Acucela; Kubota Vision
- 20 Feb 2020 According to an Acucela media release, the company has changed its name to Kubota Vision, effective from 1 Apr 2020.
- 21 Jun 2018 Results assessing effect of emixustat on retinal thickness presented in an Acucela media release.
- 17 Jan 2018 Status changed from recruiting to completed.